Clinical Trials on Atherosclerosis in Austria

Total 202 results

480 Biomedical

Completed

480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions (STANCE)

Atherosclerosis of Femoral Artery | Superficial Femoral Artery Lesions

New Zealand, Austria, Australia, Germany
Boston Scientific Corporation

Completed

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project (MAJESTIC)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, Germany, Belgium, Australia, Austria
R3 Vascular Inc.
Cardiovascular Research Foundation, New York; Massachusetts General Physicians...

Recruiting

Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease (RESOLV I)

Peripheral Arterial Disease | Lower Extremity Claudication | Lower Extremity Ischemia | Atherosclerotic Lesion

Canada, Italy, Austria
Eli Lilly and Company

Recruiting

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Elevated Lp(a) | Atherosclerotic Cardiovascular Disease (ASCVD)

United States, Australia, Spain, Canada, Argentina, China, Italy, France, Japan, Taiwan, Korea, Republic of, Denmark, Germany, Hungary, Israel, Austria, Belgium, Netherlands, Brazil, Mexico, Romania, United Kingdom, Greece, Czechia, Poland and more
Medical University of Vienna

Completed

Vienna Absolute Trial: Balloon Angioplasty Versus Stenting in the Superficial Femoral Artery

Atherosclerosis

Austria
Monash University
Novartis Pharmaceuticals

Recruiting

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) (v-ASCERTAIN)

Cerebrovascular Disease | Coronary Heart Disease (CHD) | Peripheral Arterial Disease (PAD) | Atherosclerotic Cardiovascular Disease (ASCVD)

Australia
Medical University of Vienna

Completed

Resistance to Antithrombotic Therapy (Vienna REACT)

Atherosclerosis | Angioplasty

Austria
Amgen

Active, not recruiting

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Atherosclerotic Cardiovascular Disease

United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Italy, Portugal, Greece, Hong Kong, Hungary, United Kingdom, France, Bulgaria, Germany, Finland, Japan, Sweden, Canada, Denmark, Icelan... and more
Medical University Innsbruck

Completed

Plaque Burden Pre- Myocardial Revascularisation (ByPlaque)

Atherosclerosis

Austria
VASCage GmbH

Recruiting

YOUhealTH - a Study to Improve Cardiovascular Health in Adolescents and Adults

Cardiovascular Diseases | Atherosclerosis

Austria
Band Therapeutics

Completed

A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers

Intracranial Arteriosclerosis | Cerebrovascular Stroke | Large-Artery Atherosclerosis (Embolus/Thrombosis)

Austria
NewAmsterdam Pharma
Monash University

Active, not recruiting

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

Atherosclerotic Cardiovascular Disease

Spain, United States, Israel, Italy, Denmark, United Kingdom, Canada, Poland, Latvia, Japan, Croatia, Netherlands, Australia, Finland, Slovakia, China, Czechia, Bulgaria, Georgia, Hungary, Jordan, Germany, South Africa
Medical University Innsbruck

Active, not recruiting

Atherosclerosis-Progression in Coronary Arteries Compared to Periphery Vessels (APRICOTS)

Atherosclerosis

Austria
Amgen

Completed

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Atherosclerotic Cardiovascular Disease

Canada, United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Hungary, Italy, Portugal, United Kingdom, Greece, Hong Kong, Turkey, France, Bulgaria, Germany, Finland, Japan, Sweden, ... and more
Biotronik CRC Inc.
Biotronik AG

Completed

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
Corindus Inc.

Completed

Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II (RAPID II)

Peripheral Arterial Disease

Austria
Medical University Innsbruck

Active, not recruiting

Haemodynamic and Geometric Factors in Atherosclerosis (ANGLE)

Atherosclerosis

Austria
Guerbet

Completed

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease (DALIA)

Peripheral Arterial Disease

Austria
Medical University Innsbruck

Recruiting

Mitochondrial Function in Peripheral Arterial Disease (MIVA)

Cardiovascular Diseases | Peripheral Arterial Disease

Austria
Medical University of Graz
AIT Austrian Institute of Technology GmbH

Completed

A Usability Study of a Tele-health Service for Patients With Peripheral Arterial Disease.

Peripheral Arterial Disease

Austria
Corindus Inc.

Completed

Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease (RAPID)

Peripheral Arterial Disease

Austria
Medical University of Vienna

Completed

OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Austria
Medical University of Vienna

Unknown

Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial) (PACUBA 1)

Peripheral Arterial Disease

Austria
Novartis Pharmaceuticals

Active, not recruiting

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)

Atherosclerotic Cardiovascular Disease

United States, China, South Africa, Spain, Austria, Belgium, Croatia, Estonia, Hungary, Taiwan, Turkey, Netherlands, Italy, Australia, Czechia, Denmark, France, Israel, Korea, Republic of, Thailand, Argentina, Bulgaria, Greece, Romania, Sloveni... and more
Biotronik AG

Active, not recruiting

BIO REsponse Adapted Combination Therapy Pilot Study

Peripheral Arterial Disease

Australia, Belgium, France, Germany, Austria, Spain
Medical University of Vienna

Unknown

Exercise Training Versus Best Medical Treatment Only in Peripheral Artery Disease

Peripheral Artery Disease

Austria
Novartis Pharmaceuticals

Recruiting

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Primary Prevention of Atherosclerotic Cardiovascular Disease

United States, China, Italy, Spain, France, Netherlands, Poland, Switzerland, Taiwan, Greece, Thailand, Brazil, India, Hungary, Latvia, Mexico, Israel, Malaysia, Turkey, Argentina, Singapore, Australia, Belgium, Bulgaria, Denmark, Croatia, South... and more
Medical University Innsbruck
Tiroler Landeskrankenanstalten GmbH (TILAK); Tiroler Gebietskrankenkasse (TGKK) and other collaborators

Completed

Effect of a Cardiovascular Health Promotion Program in Youth - The Tyrolean Early Vascular Ageing-study (EVA-Tyrol)

Atherosclerosis | Life Style

Austria, Italy
Medical University of Vienna
Medical Scientific Fund of the Mayor of Vienna; Austrian Heart Funds

Completed

Interval Training in Cardiac Rehabilitation

Coronary Artery Disease | Atherosclerosis

Austria
SurModics, Inc.

Completed

Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon (SWING)

Peripheral Arterial Disease | Critical Lower Limb Ischemia

New Zealand, Australia, Austria, Germany, Latvia
Medical University of Vienna
Austrian Federal Ministry of Defence and Sports

Completed

IPHAAB-study Influence of Physical Activity on Atherosclerosis Biomarkers

Influence of 8 Months of Increased Physical Activity Workload on Osteoprotegerin and Endocan Levels

Austria
Vienna General Hospital

Completed

PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents

Peripheral Vascular Diseases | Intermittent Claudication | Angioplasty

Austria
Philips Clinical & Medical Affairs Global

Completed

Tack Optimized Balloon Angioplasty Below the Knee (TOBA - BTK) Study (TOBABTK)

Peripheral Artery Disease | Critical Limb Ischemia

Austria
Boston Scientific Corporation
Beth Israel Deaconess Medical Center; Quintiles, Inc.; Medstar Health Research... and other collaborators

Completed

EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE II QCA)

Atherosclerotic Lesion(s)

New Zealand, Singapore, Australia, Japan
Bristol-Myers Squibb

Completed

Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects

Atherosclerosis

Australia
AstraZeneca
The Cleveland Clinic; IQVIA RDS Inc.

Completed

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia (STRENGTH)

Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
Prim PD Dr Afshin Assadian
Wilhelminenspital Vienna

Unknown

Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis (VUCAP)

Atherosclerosis | Carotid Artery Disease

Austria
AstraZeneca

Completed

Diabetic Under 70 (Diabetics Below 70)

Diabetes | Atherosclerosis | Hyperlipidemia

Austria
Medical University of Vienna

Unknown

Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) (NASCIT)

Atherosclerosis | Dyslipidemia

Austria
Cagent Vascular LLC

Completed

PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE (PRELUDE)

Peripheral Arterial Disease

New Zealand, Austria, Poland
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II (ACTIVATEII)

PAD - Peripheral Arterial Disease

Australia
ReFlow Medical, Inc.

Completed

A Study of the TEmporary Spur StEnt System for the Treatment of Lesions Located in the InfraPoplitEal ARteries Using a LIMUS-base DCB (DEEPER LIMUS)

Peripheral Arterial Disease | Critical Limb Ischemia

Austria
Medical University of Vienna

Unknown

Comparison of Stenting Versus Best Medical Therapy for Treatment of Ostial Renal Artery Stenosis: a Trial in Patients With Advanced Atherosclerosis

Renal Artery Stenosis

Austria
Flinders University
The Queen Elizabeth Hospital; Flinders Medical Centre; Royal Adelaide Hospital

Completed

Effect of Exercise Training on Protein Expression in Skeletal Muscle Tissue After Exercise in Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Medical University Innsbruck

Recruiting

Evaluation of Tissue Perfusion in Peripheral Arterial Disease (EVTI-PAD) (EVTI-PAD)

Peripheral Arterial Disease | Critical Limb Ischemia | Chronic Limb-Threatening Ischemia

Austria
Shockwave Medical, Inc.

Completed

Safety and Performance Study of the Shockwave Lithoplasty System (DISRUPT-PAD)

Peripheral Arterial Disease

Austria, Germany, New Zealand
Medical University of Graz
Sanofi; numares AG

Terminated

Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia (ALIROCKS)

Cardiovascular Diseases | Atherosclerosis | Hypercholesterolemia | Post Prandial Lipemia

Austria
GlaxoSmithKline

Completed

SB-659032 Platelet Aggregation Study

Atherosclerosis

Australia
Sanofi
Bristol-Myers Squibb

Completed

CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease

Arterial Occlusive Diseases

France, Spain, Italy, Belgium, Germany, Hungary, Poland, Australia, Austria, Netherlands, Sweden, United Kingdom, Finland, Switzerland
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I (REACTIVATE I)

PAD - Peripheral Arterial Disease

Australia

Clinical Trials on Atherosclerosis in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations